Ridha Essra's most recent trade in Tectonic Therapeutic Inc. was a trade of 32,834 Common Stock done . Disclosure was reported to the exchange on Feb. 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tectonic Therapeutic Inc. | Ridha Essra | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 32,834 | 32,834 (0%) | 0% | 0 | Common Stock | |
Tectonic Therapeutic Inc. | Ridha Essra | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 32,834 | 98,499 | - | - | Restricted Stock Unit | |
Tectonic Therapeutic Inc. | Ridha Essra | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 01 Feb 2024 | 16,953 | 15,881 (0%) | 0% | 1.2 | 20,354 | Common Stock |
Tectonic Therapeutic Inc. | Essra Ridha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 131,333 | 131,333 | - | - | Restricted Stock Unit | |
Tectonic Therapeutic Inc. | Essra Ridha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 183,000 | 183,000 | - | - | Stock Option (Right to Buy) | |
Tectonic Therapeutic Inc. | Essra Ridha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
Tectonic Therapeutic Inc. | Essra Ridha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
Tectonic Therapeutic Inc. | Essra Ridha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) |